NEW YORK, NY--(Marketwired - Mar 19, 2014) - IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

NEW YORK, NY--(Marketwired - Mar 24, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that it has been successful in manufacturing stromal vascular cells from Non-Living adipose ...

The Company licensed the technology for Australia & New Zealand for a one-time payment offer $700,000 and 12 1/2% Royalty Stream NEW YORK--(BUSINESS WIRE)-- Intellicell Biosciences, Inc. (OTCQB: SVFC) ...

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences Inc. (“IntelliCell” or the “Company”) today announced that its previously announced merger with Media Exchange Group, Inc. (“MEG”) (OTCQB: CWLCD) has ...

NEW YORK, NY--(Marketwired - August 21, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal ...

NEW YORK--(BUSINESS WIRE)-- IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“IntelliCell”) or the (“Company”), December 27, 2010 IntelliCell filed its patent application with the US ...

Partners will investigate stromal vascular fraction cells, the basis of IntelliCell’s product. IntelliCell BioSciences inked a sponsored research agreement with the Institute for Cell Engineering and ...

Joint pain took over Jim Cole’s life so much so that he decided to try Enbrel, a drug that he said ended up causing him more pain than relief. He stopped playing golf, his favorite past time, and didn ...

NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“Intellicell”) or the (“Company”), Intellicell has licensed its ...